Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-23

Clinical Trial Update: Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing treatment for Peripheral Artery Disease led by RWTH Aachen University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: RWTH Aachen University | Conditions: Peripheral Artery Disease | Phase 2 | Status: WITHDRAWN